(Q44326931)

2 December 2017

title

Regulation of aldose reductase and the polyol pathway activity by nitric oxide (English)

1 reference

2 December 2017

2

1 reference

2 December 2017

Satish K Srivastava

1

1 reference

2 December 2017

Deepak Chandra

series ordinal

3

1 reference

2 December 2017

Sanjay Srivastava

series ordinal

4

1 reference

2 December 2017

Aruni Bhatnagar

series ordinal

5

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Chemico-biological Interactions

2 December 2017

published in

1 reference

2 December 2017

volume

143-144

1 reference

2 December 2017

page(s)

333-340

1 reference

Aldose reductase: congenial and injurious profiles of an enigmatic enzyme

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Comparative anatomy of the aldo-keto reductase superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

The pharmacology of aldose reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Activated and unactivated forms of human erythrocyte aldose reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Identification of the reactive cysteine residue in human placenta aldose reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Modification of aldose reductase by S-nitrosoglutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Nitric Oxide Inhibits Caspase-3 byS-Nitrosationin Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S-thiolation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Carboxymethylation-induced activation of bovine lens aldose reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Nitration/S-nitrosation of proteins by peroxynitrite-treatment and subsequent modification by glutathione S-transferase and glutathione peroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Nitric oxide in the pathogenesis of vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900214-4

Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy

7 January 2021

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002182

Identifiers

DOI

10.1016/S0009-2797(02)00214-4

1 reference

2 December 2017

1 reference